Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tolvaptan add-on Therapy to Overcome Loop Diuretic Resistance in Acute Heart Failure With Renal Dysfunction

NCT04331132 is registered in ClinicalTrials.gov with Gia Dinh People Hospital as lead sponsor.

NCT NCT04331132
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04331132 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tolvaptan add-on Therapy to Overcome Loop Diuretic Resistance in Acute Heart Failure With Renal Dysfunction
Lead sponsor
Gia Dinh People Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
December 1, 2021
Completion date
July 26, 2023
Enrollment
128 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute heart failure